Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma.
about
Role Played by Signalling Pathways in Overcoming BRAF Inhibitor Resistance in Melanoma.Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol.How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.Anticancer Activity of Euplotin C, Isolated from the Marine Ciliate Euplotes crassus, Against Human Melanoma Cells.MicroRNA-365 Inhibits Cell Growth and Promotes Apoptosis in Melanoma by Targeting BCL2 and Cyclin D1 (CCND1).
P2860
Overcoming resistance to targeted therapy with immunotherapy and combination therapy for metastatic melanoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Overcoming resistance to targe ...... erapy for metastatic melanoma.
@en
Overcoming resistance to targe ...... erapy for metastatic melanoma.
@nl
type
label
Overcoming resistance to targe ...... erapy for metastatic melanoma.
@en
Overcoming resistance to targe ...... erapy for metastatic melanoma.
@nl
prefLabel
Overcoming resistance to targe ...... erapy for metastatic melanoma.
@en
Overcoming resistance to targe ...... erapy for metastatic melanoma.
@nl
P2093
P2860
P356
P1433
P1476
Overcoming resistance to targe ...... erapy for metastatic melanoma.
@en
P2093
Hilary R Keller
James W Wells
P2860
P304
75675-75686
P356
10.18632/ONCOTARGET.18523
P407
P577
2017-06-16T00:00:00Z